Showing results (121-130 of 193) with videos related to

Sort By:
Pageof 20
Journal of Personalized Medicine|April 3, 2021
PNPLA3 and SERPINA1 Variants Are Associated with Severity of Fatty Liver Disease at First Referral to a Tertiary CenterGeorg Semmler, Lorenz Balcar, Hannes Oberkofler, et al.
World Journal of Gastroenterology|February 25, 2010
Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitisSebastian Mueller, Gunda Millonig, Lucie Sarovska, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 15, 2021
PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary centerLorenz Balcar, Georg Semmler, Hannes Oberkofler, et al.
Current Issues in Molecular Biology|June 20, 2022
Molecular, Viral and Clinical Features of Alcohol- and Non-Alcohol-Induced Liver InjuryManuela G Neuman, Helmut K Seitz, Rolf Teschke, et al.
Alcoholism, Clinical and Experimental Research|September 2, 2016
Possible Mechanisms of Ethanol-Mediated Colorectal Carcinogenesis: The Role of Cytochrome P4502E1, Etheno-DNA Adducts, and the Anti-Apoptotic Protein Mcl-1Bruno Christian Koehler, Tatjana Arslic-Schmitt, Theresa Peccerella, et al.
Hepatology (Baltimore, Md.)|February 8, 2017
Caspase-cleaved keratin-18 fragments increase during alcohol withdrawal and predict liver-related death in patients with alcoholic liver diseaseSebastian Mueller, Pierre Nahon, Vanessa Rausch, et al.
Alcoholism, Clinical and Experimental Research|November 10, 2017
Carcinogenic Etheno DNA Adducts in Alcoholic Liver Disease: Correlation with Cytochrome P-4502E1 and FibrosisSebastian Mueller, Teresa Peccerella, Hua Qin, et al.
Alcohol (Fayetteville, N.Y.)|December 27, 2017
Evaluation of laboratory tests for cirrhosis and for alcohol use, in the context of alcoholic cirrhosisJohn B Whitfield, Steven Masson, Suthat Liangpunsakul, et al.
Clinical Chemistry and Laboratory Medicine|March 13, 2009
Do common genetic variants in endotoxin signaling pathway contribute to predisposition to alcoholic liver cirrhosis?Jan Petrásek, Jaroslav A Hubácek, Felix Stickel, et al.
Anti-Cancer Drugs|October 11, 2003
Weekly high-dose 5-fluorouracil as 24-h infusion and folinic acid (AIO) plus irinotecan as second- and third-line treatment in patients with colorectal cancer pre-treated with AIO plus oxaliplatinFelix Stickel, Barbara Jüngert, Valeska Brueckl, et al.
Pageof 20